Association between renal function and cardiovascular disease in patients with left ventricular hypertrophy. VIIDA study

Journal of Clinical Hypertension

Volumn 11, Issue 6, 2009, Pages 303-308

  Fácila, Lorenzo ^a   Bertomeu, Vicente ^b   Bertomeu González, Vicente ^b   Morillas, Pedro ^c   Mazón, Pilar ^c   González Juanatey, Jose R ^c  

^a Cardiology Department   (Spain)

^b Hospital de San Juan   (Spain)

^c Instituto de Salud Carlos III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGE; AGED; ARTERY DISEASE; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PREVALENCE; RISK FACTORS;

EID: 67749116074     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2009.00122.x     Document Type: Article

References (24)

1. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289(19):2560-2572.
2. Whitworth JA. World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21(11):1983-1992.
3. Ruilope LM, Salvetti A, Jamerson K, et.al. Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol. 2001;12(2):218-225.
4. Schillaci G, Reboldi G, Verdecchia P. High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension. Arch Intern Med. 2001;161(6):886-891.
5. Wang JG, Staessen JA, Fagard RH, et.al. Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension. Hypertension. 2001;37(4):1069-1074.
6. Go AS, Chertow GM, Fan D, et.al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296-1305.
7. Levey AS, Coresh J, Balk E, et.al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med. 2003;139(2):137-147.
8. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41.
9. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461-470.
10. Herrero P, Marin R, Fernandez VF, et al. Función renal y riesgo cardiovascular en pacientes con hipertensión arterial esencialEstudio FRESHA. Nefrologia. 2006;26(3):330-338.
11. Redon J, Cea-Calvo L, Lozano JV, et al. Kidney function and cardiovascular disease in the hypertensive population: The ERIC-HTA study. J Hypertens. 2006;24(4):663-669.
12. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;2(suppl 1):S1-S266.
13. Ledoux P. Cardiorenal syndrome. Avenir Med. 1951;48(8):149-153.
14. Parikh NI, Hwang SJ, Larson MG, et al. Cardiovascular disease risk factors in chronic kidney disease: Overall burden and rates of treatment and control. Arch Intern Med. 2006;166(17):1884-1891.
15. Weiner DE, Tighiouart H, Amin MG, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J Am Soc Nephrol. 2004;15(5):1307-1315.
16. Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351(13):1285-1295.
17. Facila L, Nunez J, Bodi V, et al. Valor pronóstico de la creatinina sérica en el síndrome coronario agudo sin elevación del segmento ST. Rev Esp Cardiol. 2006;59(3):209-216.
18. Bertomeu-Gonzalez V, Nunez J, Nunez E, et al. Prognostic effect of renal dysfunction after ST-segment elevation myocardial infarction with and without heart failure. Int J Cardiol. 2006;112(2):159-165.
19. Grigorian SL, Varela RA, Pedreira PM, et al. La insuficiencia renal es un predictor independiente de la mortalidad en pacientes hospitalizados por insuficiencia cardiaca y se asocia a un peor perfil de riesgo cardiovascular. Rev Esp Cardiol. 2006;59(2):99-108.
20. Silverberg DS, Wexler D, Blum M, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol. 2000;35(7):1737-1744.
21. Goodman WG, London G, Amann K, et al. Vascular calcification in chronic kidney disease. Am J Kidney Dis. 2004;43(3):572-579.
22. Kaysen GA, Eiserich JP. The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction. J Am Soc Nephrol. 2004;15(3):538-548.
23. Francis ME, Eggers PW, Hostetter TH, et al. Association between serum homocysteine and markers of impaired kidney function in adults in the United States. Kidney Int. 2004;66(1):303-312.
24. Facila L, Nunez JE, VB G, et al. Early determination of homocysteine levels in acute coronary syndromes, is it an independent prognostic factor?. Int J Cardiol. 2005;100(2):275-279.